Investigating the correlation between circulating tumor cell (CTC) detection and immune checkpoint expression in the peripheral blood of patients with small cell lung cancer (SCLC)

被引：0
|
作者：
Agelaki, S. [1 ]
Boumpouli, A. [2 ]
Nikolarakou, N. [2 ]
Vorrias, E. [3 ]
Michaelidou, K. [2 ]
Mala, A. [3 ]
Kyriakidou, A. C. [3 ]
Mavroudis, D. [1 ]
Papadaki, M. A. [2 ]
机构：
[1] Univ Crete, Lab Translat Oncol, Fac Med, Dept Med Oncol,Univ Gen Hosp Heraklion, Iraklion, Greece
[2] Univ Crete, Lab Translat Oncol, Fac Med, Iraklion, Greece
[3] Univ Gen Hosp Heraklion, Dept Med Oncol, Iraklion, Greece
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
166P
引用
下载
收藏
页码：S131 / S132
页数：2
相关论文
共 50 条
  • [41] Peripheral Immune Cell Gene Expression Predicts Survival of Patients with Non-Small Cell Lung Cancer
    Kossenkov, Andrew V.
    Dawany, Noor
    Evans, Tracey L.
    Kucharczuk, John C.
    Albelda, Steven M.
    Showe, Louise C.
    Showe, Michael K.
    Vachani, Anil
    PLOS ONE, 2012, 7 (03):
  • [42] Circulating tumor DNA detection in advanced non-small cell lung cancer patients
    Guo, Zhi-Wei
    Li, Min
    Li, Ji-Qiang
    Zhou, Chun-Lian
    Zhai, Xiang-Ming
    Li, Ming
    Wu, Ying-Song
    Yang, Xue-Xi
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 (05) : 878 - +
  • [43] Detection And Use Of Circulating Tumor Cells For Biocorrelative Analysis In Patients With Small Cell Lung Cancer
    Schwed-Lustgarten, D. E.
    Rao, C.
    Vaidya, B. K.
    Connelly, M. C.
    Langer, C.
    Vachani, A.
    Albelda, S. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [44] Detection of circulating tumor DNA in patients with advanced non-small cell lung cancer
    Yao, Yu
    Liu, Jinghao
    Li, Lei
    Yuan, Yuan
    Nan, Kejun
    Wu, Xin
    Zhang, Zhenyu
    Wu, Yi
    Li, Xin
    Zhu, Jiaqi
    Meng, Xuehong
    Wei, Longgang
    Chen, Jun
    Jiang, Zhi
    ONCOTARGET, 2017, 8 (02) : 2130 - 2140
  • [45] Circulating tumor cell analysis in patients with non-small cell lung cancer
    Kato, T.
    Yamada, K.
    Nokihara, H.
    Fukui, T.
    Yamamoto, N.
    Sekine, I.
    Kunitoh, H.
    Ohe, Y.
    Koizumi, F.
    Tamura, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [46] Efficacy and safety of immune checkpoint inhibitors (ICIs) in extensive-stage small cell lung cancer (SCLC)
    Xiaoting Ma
    Shan Wang
    Yujian Zhang
    Huamin Wei
    Jing Yu
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 593 - 606
  • [47] Tumor Immunology and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
    Jung, Chi Young
    Antonia, Scott J.
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2018, 81 (01) : 29 - 41
  • [48] The Tumor Microenvironment Affects Circulating Tumor Cells Metastasis and the Efficacy of Immune Checkpoint Blockade in Non-small Cell Lung Cancer
    Zhang, Xiuxiu
    Qiu, Sheng
    Wang, Cailian
    CURRENT CANCER DRUG TARGETS, 2024, 24 (01) : 2 - 13
  • [49] Clinical Trials Investigating Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer
    Giri, Anshu
    Walia, Simrit S.
    Gajra, Ajeet
    REVIEWS ON RECENT CLINICAL TRIALS, 2016, 11 (04) : 297 - 305
  • [50] Efficacy and safety of immune checkpoint inhibitors (ICIs) in extensive-stage small cell lung cancer (SCLC)
    Ma, Xiaoting
    Wang, Shan
    Zhang, Yujian
    Wei, Huamin
    Yu, Jing
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (02) : 593 - 606
12345